ִҵҩʦ-ҩϰ ر

5

ȷ𰸡 C

𰸽 йҩҪɷġ¼IJ 6

ȷ𰸡 C

𰸽 ݸصĵڶμԺγؾӦڹ涨¼1hеĹ涨ȻγС0.3mgڶθʱ䲻жǷѺأʴΪC 7

ȷ𰸡 A

𰸽 ָθƺ0.3mgµ ԡһ ҩ䡱֪ʶпˡ 8

ȷ𰸡 E

𰸽 ҩƷ׼ұ׼йҩ䣩׼ 9

ȷ𰸡 B

𰸽 ҩƷ׼ҩƷǰաйҩƷͨơChinese Approved Drug NamesCADNصƼԭģΪҩƷķơ 10

ȷ𰸡 A 𰸽 ¼

йҩ䡷¼ҪУƼͨͨõļⷽ춨Լԭȡ ͨüⷽһ顢ֹȷɫ׷ⶨʺͻŵIJⶨһʼ鷨ԼƼһЩ鷽ȣⶨʱӦйصķҪСҩʹõҩҺζҺȣҲӦ¼Ҫơ 11

ȷ𰸡 C

𰸽 BPƷݰƷӽṹʽʽCA¼š;ƼԴ޶ȡѧơ״𡢼顢ⶨءܵʽṹʴΪC 12

ȷ𰸡 D

𰸽 USP23ָǡҩ䡷IJָƷְӢĸ˳ȺСƷֺͼ͵IJͬÿһƷ·ֱУƷлҩĽṹʽʽԴлҩĻ

ѧơѧժCA¼šЧ۹涨װءαҪ󡢼顢Ч۲ⶨȡ 13

ȷ𰸡 B

𰸽 ҴȫΪThe National formulationдΪNF 14

ȷ𰸡 E

𰸽 ҩƷ׼ҪƷлҩĽṹʽʽͷԴлҩĻѧơЧ۵Ĺ涨Ʒ״𡢼顢Ч۲ⶨ𡢹ؼƼȡ 15

ȷ𰸡 E 𰸽 ҩ涨 ϵָ20棻 ϵָܹⲢ20棻 䴦ϵ ָ2桫l0棻 ϵָ10桫30档

ԡһ ҩ䡱֪ʶпˡ 16

ȷ𰸡 D

𰸽 ҩ涨ȡΪԼʱϵָȡó涨ġ10 17

ȷ𰸡 D 𰸽 18

ȷ𰸡 B

𰸽 йҩ䡷涨ȡ0.1gϵָȡΪ0.060.14g 19

ȷ𰸡 D

𰸽 йҩ䡷涨ԭҩĺٷδ涨ʱϵָ101.0 20

ȷ𰸡 B

𰸽 йҩ䡷涨ܱ궨ĵζҺȷʾΪKMnO4ζҺ(0.1053molL)

21

ȷ𰸡 E

𰸽 йҩ䡷涨ϵָܹҲ20 22

ȷ𰸡 D

𰸽 йҩ䡷涨䴦ϵָ210 23

ȷ𰸡 A

𰸽 Χҩ䡷涨ܻܡϵָ(1g1ml)ܼ10000mlвȫܽ 24

ȷ𰸡 B

𰸽 йҩ䡷涨ܽ⡱ϵָ(1g1ml)ܼ1mlܽ 25

ȷ𰸡 A

𰸽 л񹲺͹ҩ䡷ơйҩ䡷ӢChinese PharmacopoeiaдΪCh.P 26

ȷ𰸡 B

𰸽 йҩ䡷1990199171ִУİ桶йҩ䡷ҲΪ1751ҩƷйƷֵĺͼ롶ҩƷ׼1990棩г档 27

ȷ𰸡 D

𰸽 йҩ䡷涨ҺĵΡϵָ20棬1.0mlˮ൱20Ρ 28

ȷ𰸡 C

𰸽 йҩ䡷ȫǡл񹲺͹ҩ䡷 29

ȷ𰸡 C

𰸽 йҩ䡷l995199641ִСðҩһͶ2375ҩƷǰҩԲͬǣҩҩƷֻҩƷͨƣиҩƷȡӢҩƷ׼һ1995棩淢С 30

ȷ𰸡 C

𰸽 йҩ䡷İ䲼ΪʳƷҩƷල֡ 31

ȷ𰸡 C 𰸽 32

ȷ𰸡 D

𰸽 Ӣҩ䡷British PharmacopoeiaBPӢҩίԱơ 33

ȷ𰸡 A

𰸽 йҩ䡷2000棬ҩĸ¼˸Ľߣ¼л״ҩƷ׼ָ֤ԭҩȶָԭָԭ 34

ȷ𰸡 B

𰸽 йҩ䡷1995199641ִСðҩһͶ2375ҩƷǰҩԲͬǣҩҩƷֻҩƷͨƣиҩƷȡӢҩƷ׼һ1995棩淢С 35

ȷ𰸡 D 𰸽 36

ȷ𰸡 C 𰸽 37

ȷ𰸡 A

𰸽 ⿼ԡйҩ䡷ظϤ̶ȡ9ҩ䣬ֱΪ195319631977198519901995200020052010档鿼Ϥйҩ䡷ظ 38

ȷ𰸡 A

𰸽 йҩдΪCh.P.ŷҩдPh.Eur.E.P. 39

ȷ𰸡 C

𰸽 ҴȫΪThe National FormulationдΪNF